Alx Oncology Holdings (ALXO) Return on Sales [ROS] (2019 - 2022)
Alx Oncology Holdings' Return on Sales [ROS] came in at -9986.53% for Q1 2021, down 9186.22 percentage points from -800.31% a year earlier and down 6292.53 percentage points from the prior quarter.
Powered by 
Analysis
Alx Oncology Holdings (ALXO) Return on Sales [ROS] (2019 - 2022) Analysis & Trends
For FY2020, Alx Oncology Holdings' Return on Sales [ROS] was -3693.99%, down 3294.01 percentage points from FY2019.
- Going back by year, Return on Sales [ROS] was -399.98% in FY2019 (+262.04 pp) and -662.02% in FY2018.
- The Q1 2021 figure represents the lowest quarterly Return on Sales [ROS] in data going back to Q2 2019.
- Year-over-year, Return on Sales [ROS] has declined for four consecutive quarters, with an average year-over-year change of -3781.56 percentage points over the last four quarters.
- Business Quant data shows ALXO's Return on Sales [ROS] at -3693.99% (Q4 2020), -1401.71% (Q3 2020) and -2046.87% (Q2 2020) in the three quarters before Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 28.37% |
| 10 | Alx Oncology Holdings | 161.71 Mn | -222.26 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -1,783.01% |
| Sep 30, 2022 | -2,677.45% |
| Jun 30, 2022 | -3,857.19% |
| Mar 31, 2022 | -10,998.67% |
| Dec 31, 2021 | -135,580.95% |
| Sep 30, 2021 | -111,709.09% |
| Jun 30, 2021 | -70,865.22% |
| Mar 31, 2021 | -9,986.53% |
| Dec 31, 2020 | -3,693.99% |
| Sep 30, 2020 | -1,401.71% |
| Jun 30, 2020 | -2,046.87% |
| Mar 31, 2020 | -800.31% |
| Dec 31, 2019 | -637.51% |
| Sep 30, 2019 | -241.56% |
| Jun 30, 2019 | -323.47% |
API Access
Alx Oncology Holdings Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ALXO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ALXO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ALXO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();